Literature DB >> 22790248

Reliability of longitudinal brain volume loss measurements between 2 sites in patients with multiple sclerosis: comparison of 7 quantification techniques.

F Durand-Dubief1, B Belaroussi, J P Armspach, M Dufour, S Roggerone, S Vukusic, S Hannoun, D Sappey-Marinier, C Confavreux, F Cotton.   

Abstract

BACKGROUND AND
PURPOSE: Brain volume loss is currently a MR imaging marker of neurodegeneration in MS. Available quantification algorithms perform either direct (segmentation-based techniques) or indirect (registration-based techniques) measurements. Because there is no reference standard technique, the assessment of their accuracy and reliability remains a difficult goal. Therefore, the purpose of this work was to assess the robustness of 7 different postprocessing algorithms applied to images acquired from different MR imaging systems.
MATERIALS AND METHODS: Nine patients with MS were followed longitudinally over 1 year (3 time points) on two 1.5T MR imaging systems. Brain volume change measures were assessed using 7 segmentation algorithms: a segmentation-classification algorithm, FreeSurfer, BBSI, KN-BSI, SIENA, SIENAX, and JI algorithm.
RESULTS: Intersite variability showed that segmentation-based techniques and SIENAX provided large and heterogeneous values of brain volume changes. A Bland-Altman analysis showed a mean difference of 1.8%, 0.07%, and 0.79% between the 2 sites, and a wide length agreement interval of 11.66%, 7.92%, and 11.94% for the segmentation-classification algorithm, FreeSurfer, and SIENAX, respectively. In contrast, registration-based algorithms showed better reproducibility, with a low mean difference of 0.45% for BBSI, KN-BSI and JI, and a mean length agreement interval of 1.55%. If SIENA obtained a lower mean difference of 0.12%, its agreement interval of 3.29% was wider.
CONCLUSIONS: If brain atrophy estimation remains an open issue, future investigations of the accuracy and reliability of the brain volume quantification algorithms are needed to measure the slow and small brain volume changes occurring in MS.

Entities:  

Mesh:

Year:  2012        PMID: 22790248      PMCID: PMC7964600          DOI: 10.3174/ajnr.A3107

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  51 in total

1.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm.

Authors:  Y Zhang; M Brady; S Smith
Journal:  IEEE Trans Med Imaging       Date:  2001-01       Impact factor: 10.048

2.  Normalized accurate measurement of longitudinal brain change.

Authors:  S M Smith; N De Stefano; M Jenkinson; P M Matthews
Journal:  J Comput Assist Tomogr       Date:  2001 May-Jun       Impact factor: 1.826

3.  Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects.

Authors:  Xue Hua; Alex D Leow; Neelroop Parikshak; Suh Lee; Ming-Chang Chiang; Arthur W Toga; Clifford R Jack; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2008-07-22       Impact factor: 6.556

4.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data.

Authors:  J G Sled; A P Zijdenbos; A C Evans
Journal:  IEEE Trans Med Imaging       Date:  1998-02       Impact factor: 10.048

5.  A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

Authors:  J H Simon; L D Jacobs; M K Campion; R A Rudick; D L Cookfair; R M Herndon; J R Richert; A M Salazar; J S Fischer; D E Goodkin; N Simonian; M Lajaunie; D E Miller; K Wende; A Martens-Davidson; R P Kinkel; F E Munschauer; C M Brownscheidle
Journal:  Neurology       Date:  1999-07-13       Impact factor: 9.910

6.  MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths.

Authors:  Jorge Jovicich; Silvester Czanner; Xiao Han; David Salat; Andre van der Kouwe; Brian Quinn; Jenni Pacheco; Marilyn Albert; Ronald Killiany; Deborah Blacker; Paul Maguire; Diana Rosas; Nikos Makris; Randy Gollub; Anders Dale; Bradford C Dickerson; Bruce Fischl
Journal:  Neuroimage       Date:  2009-02-20       Impact factor: 6.556

7.  Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNbeta-1b.

Authors:  A B Rao; N Richert; T Howard; B K Lewis; C N Bash; H F McFarland; J A Frank
Journal:  Neurology       Date:  2002-09-10       Impact factor: 9.910

8.  Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis.

Authors:  M Filippi; G Mastronardo; M A Rocca; C Pereira; G Comi
Journal:  J Neurol Sci       Date:  1998-06-30       Impact factor: 3.181

9.  Accuracy assessment of global and local atrophy measurement techniques with realistic simulated longitudinal Alzheimer's disease images.

Authors:  Oscar Camara; Julia A Schnabel; Gerard R Ridgway; William R Crum; Abdel Douiri; Rachael I Scahill; Derek L G Hill; Nick C Fox
Journal:  Neuroimage       Date:  2008-05-11       Impact factor: 6.556

Review 10.  Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis.

Authors:  David H Miller
Journal:  NeuroRx       Date:  2004-04
View more
  41 in total

Review 1.  Structural Image Analysis of the Brain in Neuropsychology Using Magnetic Resonance Imaging (MRI) Techniques.

Authors:  Erin D Bigler
Journal:  Neuropsychol Rev       Date:  2015-08-18       Impact factor: 7.444

Review 2.  Segmentation of human brain using structural MRI.

Authors:  Gunther Helms
Journal:  MAGMA       Date:  2016-01-06       Impact factor: 2.310

3.  Cortical Thickness of Native Tibetans in the Qinghai-Tibetan Plateau.

Authors:  W Wei; X Wang; Q Gong; M Fan; J Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2017-01-19       Impact factor: 3.825

4.  Postmortem validation of MRI cortical volume measurements in MS.

Authors:  Veronica Popescu; Roel Klaver; Adriaan Versteeg; Pieter Voorn; Jos W R Twisk; Frederik Barkhof; Jeroen J G Geurts; Hugo Vrenken
Journal:  Hum Brain Mapp       Date:  2016-03-04       Impact factor: 5.038

Review 5.  Clinical relevance of brain volume measures in multiple sclerosis.

Authors:  Nicola De Stefano; Laura Airas; Nikolaos Grigoriadis; Heinrich P Mattle; Jonathan O'Riordan; Celia Oreja-Guevara; Finn Sellebjerg; Bruno Stankoff; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

Review 6.  Future Brain and Spinal Cord Volumetric Imaging in the Clinic for Monitoring Treatment Response in MS.

Authors:  Tim Sinnecker; Cristina Granziera; Jens Wuerfel; Regina Schlaeger
Journal:  Curr Treat Options Neurol       Date:  2018-04-20       Impact factor: 3.598

7.  Brain atrophy in cerebral small vessel diseases: Extent, consequences, technical limitations and perspectives: The HARNESS initiative.

Authors:  François De Guio; Marco Duering; Franz Fazekas; Frank-Erik De Leeuw; Steven M Greenberg; Leonardo Pantoni; Agnès Aghetti; Eric E Smith; Joanna Wardlaw; Eric Jouvent
Journal:  J Cereb Blood Flow Metab       Date:  2019-11-20       Impact factor: 6.200

Review 8.  Neuroprotection in multiple sclerosis: a therapeutic approach.

Authors:  Amir-Hadi Maghzi; Alireza Minagar; Emmanuelle Waubant
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749

Review 9.  Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease.

Authors:  François De Guio; Eric Jouvent; Geert Jan Biessels; Sandra E Black; Carol Brayne; Christopher Chen; Charlotte Cordonnier; Frank-Eric De Leeuw; Martin Dichgans; Fergus Doubal; Marco Duering; Carole Dufouil; Emrah Duzel; Franz Fazekas; Vladimir Hachinski; M Arfan Ikram; Jennifer Linn; Paul M Matthews; Bernard Mazoyer; Vincent Mok; Bo Norrving; John T O'Brien; Leonardo Pantoni; Stefan Ropele; Perminder Sachdev; Reinhold Schmidt; Sudha Seshadri; Eric E Smith; Luciano A Sposato; Blossom Stephan; Richard H Swartz; Christophe Tzourio; Mark van Buchem; Aad van der Lugt; Robert van Oostenbrugge; Meike W Vernooij; Anand Viswanathan; David Werring; Frank Wollenweber; Joanna M Wardlaw; Hugues Chabriat
Journal:  J Cereb Blood Flow Metab       Date:  2016-05-11       Impact factor: 6.200

Review 10.  MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment.

Authors:  Massimo Filippi
Journal:  J Neurol       Date:  2014-04-11       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.